By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just under 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Contact Information

Website: www.sanofi.com
Email: IR@sanofi.com
Main Phone: +33 153774000
Address: 54, Rue La Boetie
City / Town: Paris
Country: FR
Postal Code: 75008

Issuer Information

Exchange: NGS
CEO: Paul Hudson
Employees: 99412
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A